ĐÁNH GIÁ RỐI LOẠN CHUYỂN HÓA GLUCOSE, TỔN THƯƠNG TẾ BÀO GAN VÀ CHỨC NĂNG THẬN Ở BỆNH NHÂN UNG THƯ DẠ DÀY MẮC MỚI

Abstract

Objective: Gastric cancer (GC) is a global health burden. Glucose metabolism disorders, liver damage, and renal dysfunction are closely associated with the prognosis of GC patients. This study aims to evaluate the status of glucose metabolism disorders, liver damage, and renal dysfunction in newly diagnosed GC patients. Methods: This is a cross-sectional study with a case-control comparison of two groups. The study included 77 newly diagnosed GC patients and 90 healthy individuals with no detected abnormalities after routine check-ups at Military Hospital 103. Results: Fasting plasma glucose levels in GC patients were significantly higher than those in the control group (p<0.0001). A substantial proportion of newly diagnosed GC patients exhibited glucose metabolism disorders, with 31.17% having glucose levels in the prediabetes range and 23.38% in the diabetes range. The prevalence of liver damage and renal dysfunction was approximately 10%. Conclusion: Glucose metabolism disorders was prevalent among newly diagnosed GC patients. Therefore, it is necessary to screen, diagnose and aplly proactive intervention strategies for better glucose metabolism control. Liver damage and renal dysfunction were observed in approximately 10% of newly diagnosed GC patients.